News
Schaeffer Center White Paper Outlines FDA Reforms to Boost Pharmaceutical Innovation and Expand Access
September 11, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
Research
All Research Featured Research
White Paper
A Blueprint for FDA: Recommendations to Improve Innovation and Access
September 11, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
News
How a Gift Card Could Help Speed Up Alzheimer’s Clinical Research
August 22, 2025
Featured Experts: Mireille Jacobson, PhD, Doris Molina-Henry, PhD
Journal Article
Participation in Clinical Research Among Racial and Ethnic Minority Medicare Beneficiaries: Evidence from the IDEAS Study
July 22, 2025
Featured Experts: Mireille Jacobson, PhD, Sidra Haye, PhD
Journal Article
Racial Climate on Willingness to Participate in Clinical Research
July 7, 2025
Featured Experts: Rema Raman, PhD, Jevay Grooms, PhD
Evidence Base
Alzheimer’s Breakthroughs Are on the Horizon — If We Can Get Patients Into Trials
July 7, 2025
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA
Perspective
What RFK Jr. Gets Wrong About Conflicts of Interest
June 12, 2025
Featured Experts: Genevieve P. Kanter, PhD
Perspective
Agency Overreach Leaves Patients Untreated
June 10, 2025
Featured Experts: Joseph Grogan, JD
White Paper
How Does Corporate Tax Policy Influence Innovation?
June 4, 2025
Featured Experts: Karen Mulligan, PhD, Drishti Baid, MPP, Darius Lakdawalla, PhD
Evidence Base
New Alzheimer’s Blood Tests Have the Potential to Supercharge Clinical Trials
May 27, 2025
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA, Desi Peneva, MS, Mireille Jacobson, PhD, Maria-Alice Manetas
Perspective
The Biotech Industry Needs to Make Its Case for Bold Change to the White House
May 7, 2025
Featured Experts: Joseph Grogan, JD
Evidence Base
Patients Win When NIH Swings for the Fences
May 1, 2025
Featured Experts: Dana Goldman, PhD, Bob Kocher, MD
Evidence Base
Who Will Use New Alzheimer’s Drugs? Addressing Barriers to Access Is Critical
April 17, 2025
Featured Experts: Julie Zissimopoulos, PhD
Journal Article
Emerging Alzheimer’s Disease Treatment Paradigms: A Late-Stage Clinical Trial Review
December 27, 2024
Featured Experts: Jakub Hlávka, PhD, Mireille Jacobson, PhD
Evidence Base
Expanding Medicare Coverage for Cognitive Screening
December 12, 2024
Featured Experts: Joseph Grogan, JD
Perspective
Congress Must Roll Back a Key Anti-Innovation Biden-Harris Policy
September 21, 2024
Featured Experts: Joseph Grogan, JD
Comment Letter
Comments on Optimizing FDA’s Use of and Processes for Advisory Committees
August 13, 2024
Featured Experts: Genevieve P. Kanter, PhD
Comment Letter
Comments to Representatives DeGette and Bucshon on Building on the Successes of 21st Century Cures
August 8, 2024
Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD
Perspective
Access to New Alzheimer’s Treatments Bogged Down by Medicare Policy
June 17, 2024
Featured Experts: Joseph Grogan, JD
- ← Previous
- 1
- 2
- 3
- 4
- Next →